INTERNATIONAL SYMPOSIUM ON
BIOINFORMATICS & GENOMICS
January 15th – 17th, 2001
Venue:
National Science Seminar Complex
J. N. Tata Auditorium
Indian Institute of Science
Campus
Bangalore
Rapid developments in the analysis
of microbial and human genes (genomics) as well as the analysis of gene
products and their expression (proteomics) have revolutionized biomedical
sciences in the 21st century. New technologies have been developed to simultaneously
assess the levels of expression of many thousands of different genes using
DNA microarrays.
Thus, monitoring the expression of
thousands of gene products will undoubtedly generate enormous volumes of
data which need to be analysed. This need has resulted in a new discipline
called “Bioinformatics”. In the age of unprecedented advances in IT, the
developments in genomics / proteomics / bioinformatics clearly offer unique
opportunities in the field of Life Sciences with particular reference to
new and novel drug discovery for human, animal and plant diseases.
To bring these developments to the
scientific, industrial and investment community in India, an International
Symposium on Bioinformatics and Genomics has been organised by the Confederation
of Indian Industry (CII), in conjuntion with Government of Karnataka’s
Biotechnology Task Force, AstraZeneca Research Foundation, India and The
Biocon India Group.
This symposium will be the first
of its kind to be held in India and is structured with a series of lectures
from international experts in the emerging and challenging domain of Bioinformatics
& Genomics. As the name suggests, Bioinformatics is a fusion of
information technology and biotechnology or very simply, the application
of computer technology in the management of biological information. The
nomenclature of Genomics and Proteomics is used to denote the use of Bioinformatics
for mining generic and protein-related databases respectively.
The explosion of data being generated
from the Human Genome Project as well as from generic studies of microbial
and plant systems together with High Throughput Screening programmes in
drug research has created the need for high computing power and specialised
software to enable biologists and geneticists to mine such data. The Human
Genome Project (HGP) alone will result in sequencing data equivalent to
about 3 billion base pairs.
Bioinformatics will now provide an
integrated approach of mining the voluminous data generated by the HGP
to identify and understand human diseases and to develop corresponding
drug and gene based therapies. The importance of Bioinformatics is gaining
rapid acceptance and bioinformatics groups comprising computational biologists,
computer scientists as well as computer engineers are being constituted
at Universities, pharmaceutical and biotechnology companies and at national
research institutes.
Bioinformatics is still in its nascency
in the country as a whole but India’s strong IT base provides an enormous
opportunity for Indian companies to make rapid strides for exponential
growth in this emerging sector.
The major topics that will
be covered during the three days symposium are as follows:
1) Leveraging Advances in Information
Technology for Application in Life Sciences:
· Knowledge Driven Directions
in Pharmaceutical Research
· Information Management in
Biotechnology
2) Genomics and its Impact on
Biotechnology:
· Integration of Genomics
into Life Sciences R&D
· Advanced Technologies in
Gene Discovery
3) The Biotech Business:
· Intellectual Property and
Human Resource Issues
· Financing of Biotechnology
Enterprises
|